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GIST is the commonest mesenchymal tumour of the gastrointestinal tract. Jejunal GIST is rare and spontaneous
perforation of asymptomatic jejunal GIST is unique. A review of the English literature reveals only fifteen cases of
perforated GIST till date. Pre-operative diagnosis is difficult. Diagnosis is confirmed on histopathology and immuno-
histochemistry. Complete removal with postoperative imatinib therapy entails optimal treatment. Perforated GIST is
associated with high recurrence.
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Gastro-intestinal stromal tumour (GIST) is most com-
mon mesenchymal tumour of gastrointestinal tract (G.I)
tract (80%) [1]. The incidence of GIST is 10–20 million
people per year with a malignant potential of 20-30%
[1,2]. Presentations include abdominal mass (5-50%), ob-
struction (5%), haemorrhage and rarely perforation
(0.8%) [1,2]. Spontaneous perforation of jejunal GIST is
rare (Table 1) and unique. This article is an illustration
of a similar case.Case presentation
Forty six year old male presented to the emergency de-
partment with pain epigastrium, constipation, nausea,
vomiting, fever and abdominal distension since two days.
He had a past history of acid peptic disorder for which
he was treated conservatively. On physical examination,
patient was conscious and of normal built. Pallor, cyan-
osis, icterus and edema were absent. He was normoten-
sive (124/70 mmHg), had tachycardia (110/min), fever
(102.4°F) and hurried respiration (25/min). Abdominal
examination revealed distension, board like rigidity,
marked rebound tenderness, absent liver dullness and
inaudible bowel sounds. Hernia sites were normal. Per-* Correspondence: utpalde@vsnl.net
1Department of surgery, Medical College Hospital, 88, College Street, Kolkata
73, India
2Dankuni Housing Complex, L-4/9, Ph 3, Dankuni, Hooghly 713211, India
© 2012 Roy et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orrectal examination did not reveal any significant abnor-
mality. Examinations of other systems were within nor-
mal limits. A provisional diagnosis of peptic perforation
was made.
Exploratory laparotomy was planned. Hematological
examination revealed mild anemic with neutophilic
leucocytosis [Hemoglobin – 9.8 g/dl, Total count-
14,000/cu.mm (N85, L11, E10, B0, M0)]. Blood sugar
(113 g/dl), liver function tests and serum electrolytes
(Na-136 meq/lit, K- 4.2 meq/lit) were within normal
limits. Viral markers were non-reactive. Abdominal
roentgenogram showed free gas under both domes of
diaphragm with diffuse ground glass opacity. Excessive
gas in the abdomen with free fluid was noted in abdom-
inal sonography.
The patient was resuscitated with intravenous fluids,
ryles tube and antibiotics. Following adequate resuscita-
tion, the patient was put up for operation. Midline lapar-
otomy revealed purulent free fluid with flakes. On
aspiration and removal of the flakes and fluid, a purplish
coloured firm growth with everted margins, measuring
3×2 cm was found in the anti-mesenteric border of the
jejunum, fifty cm from the duodeno-jejunal flexure. The
growth had a central perforation with intestinal contents
effusing through the rent (Figure 1). All other organs
were normal. The growth was resected with five cm
margin and an end to end, single layer, interrupted,
anastomosis was performed using 2000 polyglycolic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Table showing published case reports on jejunal perforation
Serial number Country Journal Patient paticulars Date of publication
1 Greece Journal of gastro-intetinal and liver diseases 66 yrs/ M 2006
2 * China Journal of Chinese oncology 69 yrs/ M 2008
3 Ankara Turkish journal of gastroenterology 70 yrs/ M 2008
4 Turkey Gastroenterology research 52 yrs / F 2009
5 Japan Journal of abdominal emergency medicine 56 yrs/ M 2009
6 * China International journal of gastroentrology 69 yrs/ M 2009
7 Greece World journal of surgical oncology 28 yrs/ F 2010
8 Istanbul Turkish journal of gastroenterology 65 yrs/ M 2010
9 India International journal of biomedical research 68 yrs / M 2010
10 India Bombay hospital journal 55 yrs/ M 2011
11 China Turkish journal of gastroenterology 45 yrs/ M 2011
12 Greece journal of current surgery 56 yrs/ M 2011
13 Turkey Journal of clinical and analytical medicne 61 yrs/ F 2012
14 India The internet journal of surgery 35 yrs/ M 2012
15 India Indian journal of surgery 22 yrs/ M 2012
* same case report published in different journal.
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normal saline and abdomen was closed in layers. A tube
drain was placed in the hepatorenal pouch of Morrison.
The specimen was sent for histopathological examination.
Post operative period was uneventful and the patient was
discharged on the tenth post-op day after stitch removal.
Histopathology (Figure 2) of the resected specimen
showed, a submucosal nodular tumour composed of inter-
lacing fascicles of spindle shaped cells with elongated,
plump nuclei. There was mild nuclear pleomorphism and
more than five mitotic figures per fifty high power fields.Figure 1 Peroperative photograph showing jejunal gist with
perforation.No tumour necrosis found. Pathologically it was jejunal
GIST of intermediate risk. Surgical lines of resection were
free. Immuno-histochemistry study revealed diffuse immu-
noreactivity for CD-117 (Figure 3), focal CD-34 positivity,
negative for desmin, S-100 and SMA;Ki 67 less than 5%.
The patient is on six months follow-up receiving oral
imatinib 300 mg twice a day.
Conclusion
GIST was first described by Mazor and Clark (1983) [1].
It originates from the interstitial cells of Cajal (ICC),
located in the muscularis propria (myenteric plexus) respon-
sible for triggering smooth muscle contraction [2,3]. TheFigure 2 Histopathology of jejunal GIST.
Figure 3 Immunohistochemistry for CD117 positivity.
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of chromosome 4 which codes for c-Kit resulting in uncon-
trolled proliferation of stem cells that differentiate towards
ICC. GIST is sporadic [3]. Familial forms with autosomal
dominant inheritance have also been documented [3,4].
Isolated reports of GIST occurring concomitantly with
paraganglioma, pulmonary chondroma, nerofibromatosis,
pancreatic neuro-endocrine tumours, burkitt’s lymphoma,
osteosarcoma, neuroblastoma and melanoma have been
documented [4].
90% of GIST occurs in adults more than 40 years of age
(median age 63 years). There is slight male preponderance
[4]. No documented elements indicating any association
with geographic location, ethnicity, race or occupation has
been elucidated [4,5].
The commonest site of GIST is stomach (60-70%)
[2,3]. Jejunum accounts for 10% of all GI tract GIST’s
[1,3]. Sporadic reports of GISTs arising from the omen-
tum, mesentery or retroperitoneum, have been docu-
mented but most of these are metastatic from gastric or
intestinal primaries [4]. Extra-GIST has been reported in
gall bladder, pancreas, liver and urinary bladder [4].
Presentation is erratic. Seventy percent are symptomatic at
presentation, 20% are asymptomatic and 10% are detected at
autopsy [5,6]. Common presentations include abdominal
pain, palpable mass, gastro intestinal bleeding, fever, anorexia,
weight loss and anaemia [7]. Isolated jejunal GIST associated
with perforation and peritonitis is a rare and unique [1].
Perforation is usually attributed to replacement of bowel
wall by tumour cells, tumour embolization leading to is-
chemia, necrosis together with raised intra-luminal pres-
sure [4,5,7]. In view of the exophytic nature of the growth,
intestinal obstruction occurs due to compression ratherthan luminal obstruction. As such intetstinal obstruction is
a rare occurrence until the tumour attains enormous size.
Clinical diagnosis of GIST is based on index of suspicion
[6,7]. Specific diagnostic signs and symptoms are absent.
Chronicity is a rule. Acute atypical presentation includes
hemorrhage and perforative peritonitis [1-10]. Preopera-
tive imaging modalities like contrast enhanced abdominal
computerized tomography (CT) aids in diagnosis [8]. The
extent of the tumor, metastases and involvement of other
organs can be assessed. A dedicated magnetic resonance
imaging (MRI) provides better information than CT in the
preoperative staging workup [7,8]. Endoscopy can diag-
nose gastric GISTs. Endoscopy demonstrates smooth,
mucosa-lined protrusion of the bowel wall which may or
may not show signs of bleeding or ulceration. Endoscopic
ultrasound with guided fine-needle aspiration is diagnostic
for primary lesions in 89% of the cases [8-10]. However,
the relative usefulness of images depends on the site, dur-
ation and suspicion of GIST in patients presenting with
undiagnosed abdominal lumps. The decisive diagnosis
rests on the pathological and immunohistological tests
[2,5-10]. Histopathologically GISTs are composed of spin-
dle (70%), epithelioid and round cell or an admixture
[6,8]. Similarities with histological picture of gastro-
intestinal leiomyosarcoma, leiomyoblastoma and poorly
differentiated carcinomas may cause diagnostic dielemma,
Immuno-histochemical assays for CD117 antigen (KIT) is
the mainstay for diagnosis [9,10].
Diagnosis of asymptomatic GIST with acute prese-
ntation like perforation remains elusive. Accordingly,
our provisional diagnosis was peptic perforation as free
gas under diaphragm was noted in erect abdominal
rhoentgenogram.
Optimal surgical treatment of GIST entails complete
removal of the tumor with clear surgical margins inc-
luding the adjacent involved organs [5-10]. Complete
surgical resection entails 48-65% five-year survival [1].
Perforation of the tumor lowers the five-year survival to
24%, probably due to peritoneal dissemination [5]. Local
and regional lymph node involvement is infrequent in
GIST [6,8,10]. GIST’s presenting with perforation, atten-
tion needs to be paid, in view of possible recurrence of
the tumor. Abundant peritoneal lavage should be per-
formed with distilled water to reduce the risk of periton-
eal tumour spillage. Distilled water is used because of its
cytolytic activity on suspended cells [7,9,10].
GIST response to conventional chemotherapy is very
poor (<10%), while radiotherapy is only used in cases of
intraperitoneal hemorrhage, when the precise location of
the tumor is known, or for analgesic purposes [7,8].
STI571 (imatinib), acts as a powerful selective inhibi-
tor of tyrosine-kinase, PDGFR (platelet derived growth
factor receptor) and c-kit receptor [10]. Oral imatinib at
doses >300 mg per day achieves curative results.
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tation, anatomic location, size (most important), histo-
morphology, immuno-histochemistry and molecular
genetics [4,6-10].
Positron-emission tomography with 18F-fluoro-2-
deoxy-D-glucose is a very useful tool for the postopera-
tive follow-up of patients receiving imatinib [4,5,9,10].
The 5-year survival rate is 35%. It increases to 54%
after complete surgical excision [1-10]. However 40%
will recur within 18 – 24 months. Once recurrence has
occurred median survival is 9–16 months [3,5,7,8,10].
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